Trouver une offre

Show Filter
CELLECTIS

QUALITY UNIT DIRECTOR – GMP Facility (M/F)

Cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited T-cells (UCART). By capitalizing on its 18 years of expertise in gene…
CELLECTIS
Biotechnologie
CELLECTIS

QUALITY CONTROL DIRECTOR – GMP Facility Paris (M/F)

Cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited T-cells (UCART). By capitalizing on its 18 years of expertise in gene…
CELLECTIS
Biotechnologie
CELLECTIS

Logistics Specialist (M/F)

Cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited T-cells (UCART). By capitalizing on its 18 years of expertise in gene…
CELLECTIS
Biotechnologie
CELLECTIS

Expert Viral vector production (H/F)

Cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited T-cells (UCART). By capitalizing on its 18 years of expertise in gene…
CELLECTIS
Biotechnologie
laporte euro

Ingénieur Qualification/Validation procédés pharmaceutiques H/F

Laporte Euro – siège à Nantes, 4 agences Nantes, Paris, Lyon et Pau, 50 collaborateurs - est la filiale européenne du Groupe Laporte Experts Conseils, bureau d'étude canadien de 330 personnes,…
laporte euro
Biotechnologie, Cosmétique, Pharmaceutique, Production/Logistique
NOVARTIS

Team Leader (Bioanalytics), Manufacturing Science & Technology / Manager Bioanalytique

 About Novartis A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented,…
NOVARTIS
Biotechnologie, Méthodes et procédés analytiques, Pharmaceutique, R&D
Afin de vous proposer le meilleur service possible, A3P Opportunities utilise des cookies. En continuant de naviguer sur le site, vous déclarez accepter leur utilisation.